Compare, Analyse Jubilant Pharmova with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT PHARMOVA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 JUBILANT PHARMOVA    ADCOCK INGRAM
EQUITY SHARE DATA
    JUBILANT PHARMOVA
Mar-20
ADCOCK INGRAM
Jun-14
JUBILANT PHARMOVA /
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs727376-   
Low Rs230271-   
Sales per share (Unadj.) Rs574.7111.7-  
Earnings per share (Unadj.) Rs56.4-28.1-  
Cash flow per share (Unadj.) Rs85.4-23.3-  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs351.887.7-  
Shares outstanding (eoy) m159.28168.78-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.82.9 28.8%   
Avg P/E ratio x8.5-11.5 -73.9%  
P/CF ratio (eoy) x5.6-13.9 -40.4%  
Price / Book Value ratio x1.43.7 36.9%  
Dividend payout %8.90-   
Avg Mkt Cap Rs m76,22054,555 139.7%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m21,2773,424 621.4%   
Avg. sales/employee Rs ThNM4,392.1-  
Avg. wages/employee Rs ThNM797.6-  
Avg. net profit/employee Rs ThNM-1,106.7-  
INCOME DATA
Net Sales Rs m91,54418,855 485.5%  
Other income Rs m474132 359.2%   
Total revenues Rs m92,01818,987 484.6%   
Gross profit Rs m19,124-3,267 -585.3%  
Depreciation Rs m4,619814 567.6%   
Interest Rs m2,874511 562.7%   
Profit before tax Rs m12,105-4,460 -271.4%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,123279 1,120.6%   
Profit after tax Rs m8,982-4,751 -189.1%  
Gross profit margin %20.9-17.3 -120.6%  
Effective tax rate %25.8-6.2 -412.9%   
Net profit margin %9.8-25.2 -38.9%  
BALANCE SHEET DATA
Current assets Rs m50,38313,810 364.8%   
Current liabilities Rs m26,1907,770 337.1%   
Net working cap to sales %26.432.0 82.5%  
Current ratio x1.91.8 108.2%  
Inventory Days Days7111 5.9%  
Debtors Days Days52124 41.6%  
Net fixed assets Rs m72,7218,050 903.4%   
Share capital Rs m15988 182.0%   
"Free" reserves Rs m55,8800-   
Net worth Rs m56,03914,799 378.7%   
Long term debt Rs m37,3975,201 719.1%   
Total assets Rs m123,10427,957 440.3%  
Interest coverage x5.2-7.7 -67.4%   
Debt to equity ratio x0.70.4 189.9%  
Sales to assets ratio x0.70.7 110.3%   
Return on assets %9.6-15.2 -63.5%  
Return on equity %16.0-32.1 -49.9%  
Return on capital %16.0-19.8 -80.9%  
Exports to sales %00-   
Imports to sales %14.80-   
Net fx Rs m2,0000-   
CASH FLOW
From Operations Rs m15,4291,609 958.7%  
From Investments Rs m-3,270-494 661.7%  
From Financial Activity Rs m-10,5044,720 -222.5%  
Net Cashflow Rs m2,2545,835 38.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.18 Rs / ZAR

Compare JUBILANT PHARMOVA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare JUBILANT PHARMOVA With: HEMO ORGANIC  GODAVARI DRU  BHARAT PARENTALS  IND. SWIFT  NGL FINE CHM  



Today's Market

TRAI Data for March, Proposal for 100% FDI in Oil PSUs, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a positive note yesterday. Benchmark indices bounced back from early losses and ended on a positive note as India opened free inoculation for all citizens on Monday.

Related Views On News

Jubilant Pharmova Drops 6% on Weak March Quarter Numbers (Views On News)

Jun 8, 2021

Here's a rundown on the latest quarterly results of Jubilant Pharmova.

Points to Keep in Mind Before Subscribing to Krishna Institute of Medical Sciences' IPO (Views On News)

Jun 15, 2021

All you need to know about the IPO of Krishna Institute of Medical Sciences.

Why Did Shares of Divi's Lab Rally Today? (Views On News)

Jun 10, 2021

The stock jumped 3.6% in intraday trade to hit its 52-week high.

Laurus Labs Hits New Life High. Up 500%+ in One Year (Views On News)

Jun 8, 2021

Laurus Labs trades higher for the eight straight day, soars 73% in 3 months.

Lupin Gains 16% in a Month. Here's Why it Could Rally More (Views On News)

Jun 4, 2021

Recent developments in digital healthcare and revised targets by brokerages send Lupin shares flying.

More Views on News

Most Popular

My 'Unlock' Investments (Fast Profits Daily)

Jun 11, 2021

The best unlock investments you can make in the market.

How I Discovered a 400-Year-Old Open Secret to Extreme Wealth (Profit Hunter)

Jun 11, 2021

Charlie Munger's open secret about investing success.

The Most Visible Sign of India's Revival is on Two Wheels (Profit Hunter)

Jun 9, 2021

Investing in the best stocks could result in wealth compounding on a massive scale.

Wednesday's Market Fall Explained (Fast Profits Daily)

Jun 10, 2021

This is why the stock market fell the way it did on Wednesday.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

JUBILANT PHARMOVA SHARE PRICE


Jun 21, 2021 (Close)

TRACK JUBILANT PHARMOVA

  • Track your investment in JUBILANT PHARMOVA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT PHARMOVA

JUBILANT PHARMOVA 5-YR ANALYSIS

COMPARE JUBILANT PHARMOVA WITH

FEATURED VIDEOS

The 3-Word Secret to Earning Incredible Returns

Buy & Hold v/s In & Out Investing

An Investing System that Found 20 Winners in a Row

Top Pick for Next Decade

More Featured Videos

MARKET STATS